ConductScience.org, home

Paper40260239

Mechanisms of HDACs in cancer development.

Zhang Y and 4 others. Front Immunol, 2025. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms of HDACs in cancer development. Papers, record 40260239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40260239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of HDACs in cancer development.
PubMed
Journal
Front Immunol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
12.67, provisional
iCite
Revised in PubMed
2025-04-23
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYing
2Wang HHaotian
3Zhan ZZhumei
4Gan LLin
5Bai OOut

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Histone Deacetylase InhibitorsMajor topic
Histone DeacetylasesMajor topic
Humans
Epigenesis, Genetic
Animals
Tumor Microenvironment
Antineoplastic Agents

Source PubMed

Download CSV of topics

References203

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123939379Histone deacetylase regulation of ATM-mediated DNA damage signaling.Mol Cancer Ther2013https://conductscience.org/library/papers/23939379PubMed
221596753miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.J Biol Chem2011https://conductscience.org/library/papers/21596753PubMed
316511565Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.EMBO J2006https://conductscience.org/library/papers/16511565PubMed
426240284Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway.Mol Cell Biol2015https://conductscience.org/library/papers/26240284PubMed
530582912Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals.Eur J Pharmacol2019https://conductscience.org/library/papers/30582912PubMed
621685935EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.Oncogene2012https://conductscience.org/library/papers/21685935PubMed
728126962Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study.Haematologica2017https://conductscience.org/library/papers/28126962PubMed
825131830Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.Nat Rev Drug Discov2014https://conductscience.org/library/papers/25131830PubMed
921247901Histone deacetylases 9 and 10 are required for homologous recombination.J Biol Chem2011https://conductscience.org/library/papers/21247901PubMed
1010597302Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53.Oncogene1999https://conductscience.org/library/papers/10597302PubMed
1128860342CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial.Haematologica2017https://conductscience.org/library/papers/28860342PubMed
1212494463Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells.Int J Cancer2003https://conductscience.org/library/papers/12494463PubMed
1323088871Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activity.Adv Cancer Res2012https://conductscience.org/library/papers/23088871PubMed
1435170082Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.Am J Hematol2022https://conductscience.org/library/papers/35170082PubMed
1535552447Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer.Oncologist2022https://conductscience.org/library/papers/35552447PubMed
1630868056Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.FEBS Open Bio2019https://conductscience.org/library/papers/30868056PubMed
1722961641Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.Stem Cells2012https://conductscience.org/library/papers/22961641PubMed
1822301920HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells.Cell Death Differ2012https://conductscience.org/library/papers/22301920PubMed
1925107918Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors.Clin Cancer Res2014https://conductscience.org/library/papers/25107918PubMed
2015301879Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer.Lung Cancer2004https://conductscience.org/library/papers/15301879PubMed

See all 203 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
42948158New sulfonamide derivatives as HDAC inhibitors and apoptosis inducers: design, synthesis, in silico study and anticancer evaluation.RSC Adv2026https://conductscience.org/library/papers/42948158PubMed
42883867Targeting Aromatase and HDACs in Hormone Receptor-Positive Breast Cancer: Molecular Interplay, Endocrine Resistance and Therapeutic Opportunities.Int J Mol Sci2026https://conductscience.org/library/papers/42883867PubMed
42830998Membrane-associated HDAC11: A potential new therapeutic targeting compartment in cancer cells.Biochem Biophys Rep2026https://conductscience.org/library/papers/42830998PubMed
42792755Epigenetic Plasticity in Triple-Negative Breast Cancer: Mechanisms of Therapy Resistance, Biomarkers, and Therapeutic Vulnerabilities.Biomedicines2026https://conductscience.org/library/papers/42792755PubMed
42750032The roles of chromatin remodeling and 3D genome organization in cancers: from mechanistic insights to emerging treatment options.Mol Cancer2026https://conductscience.org/library/papers/42750032PubMed
42661166
Exploration of novel hydroxamic acid-based candidates integrating chalcone scaffold cap as multitarget HDAC inhibitors: design, anti-prostatic cancer assessment, in silico docking and molecular dynamic simulation.
J Enzyme Inhib Med Chem2026https://conductscience.org/library/papers/42661166PubMed
42517085HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism.EXCLI J2026https://conductscience.org/library/papers/42517085PubMed
42478333Expression Levels of DNMT1, HDAC1, and MT1E Genes as Diagnostic Biomarkers for Breast Cancer Clinicopathological Features: In Vitro and In Silico Analyses.Anal Cell Pathol (Amst)2026https://conductscience.org/library/papers/42478333PubMed
42290054[Potential Mechanisms and Research Advances of HDAC1 in Lung Cancer].Zhongguo Fei Ai Za Zhi2026https://conductscience.org/library/papers/42290054PubMed
42199345Epigenetic dysregulation in mycosis fungoides and sézary syndrome.Front Cell Dev Biol2026https://conductscience.org/library/papers/42199345PubMed
42059134Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.J Med Chem2026https://conductscience.org/library/papers/42059134PubMed
41957661Deciphering epigenetic crosstalk in multiple myeloma pathogenesis and treatment.Clin Epigenetics2026https://conductscience.org/library/papers/41957661PubMed
41828436Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.Int J Mol Sci2026https://conductscience.org/library/papers/41828436PubMed
41783166Histone deacetylases: Function in tumor development and therapeutic prospects (Review).Oncol Lett2026https://conductscience.org/library/papers/41783166PubMed
41686481Structure-activity insights and molecular modeling approaches of anti-TNBC agents: a comprehensive systematic review.Future Sci OA2025https://conductscience.org/library/papers/41686481PubMed
41593801Differential transcriptomic modulation by histone deacetylase inhibitor SAHA in LUAD and LUSC.Clin Epigenetics2026https://conductscience.org/library/papers/41593801PubMed
41498889Role of HDAC6 in carcinomas.Discov Oncol2026https://conductscience.org/library/papers/41498889PubMed
41465319Microenvironmental and Molecular Pathways Driving Dormancy Escape in Bone Metastases.Int J Mol Sci2025https://conductscience.org/library/papers/41465319PubMed
41463266In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma.Cancers (Basel)2025https://conductscience.org/library/papers/41463266PubMed
41452386Epigenomic landscape of nasopharyngeal carcinoma.Med Oncol2025https://conductscience.org/library/papers/41452386PubMed

See all 33 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40260239

GET https://conductscience.org/api/papers/v1/40260239/references?page=2